Tools for rapid identification of novel and/or emerging viruses are urgently needed for clinical diagnosis of unexplained infections and pandemic preparedness. Here we developed and clinically ...
The U.S. Bloodstream Infection Testing Market is projected to grow from USD 221.68 Million in 2025 to USD 355.49 Million by ...
Researchers have discovered a strategy to neutralize two highly lethal viruses for which there is currently no approved vaccine or cure. A team led by Professor Daniel Watterson and Dr. Ariel Isaacs ...
The DRC has improved testing capacity for Ebola with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
Streamlining Respiratory Virus Testing with Molecular Diagnostics: Impact on patients and laboratory
Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...
The diseases were removed from a list of tests the agency conducts for state and local health departments. Experts worry that with drastic staff reductions, the testing may not resume. By Apoorva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results